Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05815537 · ClinicalTrials.gov registry record · Early Phase 1
Development of Functional Spatial Hearing in Reverberation
A Early Phase 1 study, sponsored by Father Flanagan's Boys' Home.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 116
- Enrollment target
NCT05815537: Completed Early Phase 1 study, sponsored by Father Flanagan's Boys' Home.
NCT05815537 is a Early Phase 1 study that has completed, run by Father Flanagan's Boys' Home. The registered enrollment target is 116 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (119% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05815537, a Early Phase 1 study, has completed, sponsored by Father Flanagan's Boys' Home.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 116 participants
- Enrollment target
Study Summary
The goal of the clinical trial study (Phase 0) is to map out the developmental trajectory of functional spatial hearing abilities in reverberant environments for children with normal hearing between the ages of 6 and 18 years, and to understand the inter-relationships between the three perceptual abilities: auditory object size formation, spatial acuity, and spatial unmasking during typical development. Children are asked to perform psychoacoustic tasks when the auditory stimuli are processed to present in virtual acoustic environments (1) with no reverberation and (2) with one of the two levels of reverberation that emulate everyday indoor environments. The intervention of this clinical study is in the random assignment of one of the two reverberant environments. Researchers will compare these children with a group of normal-hearing adults to anchor matured performances.
Primary Outcome
Psychoacoustic measure of the smallest detectable change in width of an auditory image in degree angular span in the horizontal plane
Interventions
- OTHER Low-Reverberation
- OTHER High-Reverberation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-03-01 |
| Phase | Early Phase 1 |
What the finished NCT05815537 record still lists
NCT05815537 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (119% higher).
The record links to 0 conditions, and to 2 interventions - of which Low-Reverberation is the first listed.
NCT05815537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05815537 about?
NCT05815537 is a clinical study titled "Development of Functional Spatial Hearing in Reverberation". The goal of the clinical trial study (Phase 0) is to map out the developmental trajectory of functional spatial hearing abilities in reverberant environments for children with normal hearing between the ages of 6 and 18 years, and to understand the inter-relationships between the three perceptual ab...
What is the current status of trial NCT05815537?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 116 participants. The study started on 2024-01-01. Estimated completion is 2026-03-01.
What interventions are being tested in trial NCT05815537?
The interventions under investigation include: Low-Reverberation (OTHER), High-Reverberation (OTHER).
Who is sponsoring clinical trial NCT05815537?
This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05815537's enrollment target sits among peer trials
116 158th of 2000 higher than 1,840 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI